![Douglas Pagán](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Pagán
Director of Finance/CFO at
Jnana Therapeutics, Inc.
Profile
Douglas W.
Pagán is currently Chief Operating & Financial Officer at Jnana Therapeutics, Inc. since 2022 and Chief Financial Officer at Kailera Therapeutics, Inc. starting in 2025.
Former roles include Finance Director at Biogen, Inc., Independent Director at Alaunos Therapeutics, Inc. from 2018 to 2020, Manager-International Treasury at Bristol Myers Squibb Co., Senior Engineer at Johnson & Johnson, Vice President-Finance at Acceleron Pharma, Inc. from 2008 to 2014, Chief Financial Officer at Dicerna Pharmaceuticals, Inc., Principal at JPMorgan Investment Bank, Chief Financial & Accounting Officer at Paratek Pharmaceuticals, Inc. from 2014 to 2019, and Chief Financial Officer & Secretary at KSQ Therapeutics, Inc. from 2019 to 2020.
Education includes an undergraduate degree from Princeton University in 1993 and an MBA from Columbia Business School in 2001.
Douglas Pagán active positions
| Companies | Position | Start |
|---|---|---|
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Director of Finance/CFO | 2022-04-25 |
Former positions of Douglas Pagán
| Companies | Position | End |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 2020-09-17 |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Director of Finance/CFO | 2020-05-30 |
| PARATEK PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-04-04 |
| ACCELERON PHARMA INC. | Director of Finance/CFO | 2014-11-30 |
| DICERNA PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Training of Douglas Pagán
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
JPMorgan Investment Bank
 JPMorgan Investment Bank Investment Banks/BrokersFinance Operates as an investment banking firm | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
- Stock Market
- Insiders
- Douglas Pagán
